Pursuant to PhilHealth Resolution No. 349, s. 2000, the Philippine Health Insurance Corporation (PhilHealth) has approved the drug Ketorolac for inclusion to its positive list. Claims for this drug will be reimbursed only when used for short-term management of acute peri-operative pain.

DRUG	PREPARATION
Ketorolac trometamol	30 mg/ml ampule

This circular shall take effect on all admissions starting 01 October 2002 and expires 01 October 2003 if, by then, the drug is not included in the Philippine National Drug Formulary.

Adopted: 02 Sept. 2002

(SGD.) FRANCISCO T. DUQUE III, M.D., M.Sc.
President and CEO